Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
570 Leser
Artikel bewerten:
(2)

caresyntax raises USD100 million to accelerate digitalisation of operating rooms

DJ caresyntax raises USD100 million to accelerate digitalisation of operating rooms

DGAP-Media / 2021-04-28 / 11:57 
caresyntax raises USD100 million to accelerate digitalisation of operating rooms 
 . USD100 million raised in oversubscribed Series C round 
 . One of the largest funding rounds for a German healthcare venture 
 . New investors include PFM Health Sciences LP, Optum Ventures, Intel Capital, and Lauxera Capital Partners, with 
  participation of existing investors Relyens Group, IPF Partners and surgical.ai 
 . Funding to drive expansion in key markets and further strengthen AI capabilities 
BERLIN & BOSTON, 28^th April 2021 - caresyntax, the pioneer in digital surgery, hospital performance analytics, and AI, 
today announced it has raised USD100 million in additional growth capital, one of the largest funding rounds in the 
German healthcare space to date. The Series C round was led by PFM Health Sciences LP, Optum Ventures, Intel Capital, 
Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, along with current investors IPF 
Partners, Relyens Group and surgical.ai. The investment follows a year in which the company saw 250% growth, supported 
more than 30,000 surgeons, and improved care for more than 2 million patients. 
"We are grateful to our new and existing investors who support our vision of safer and smarter surgery," said Björn von 
Siemens, caresyntax Co-Founder and CBO. "The last year accelerated the healthcare industry's massive transformation of 
becoming a truly data-enabled and patient-centric space. We are excited to be at the forefront of the digital 
revolution in surgery." 
Operating rooms are the financial heart of hospitals. They always need to perform as effectively and efficiently as 
possible - especially now with the surgical backlog resulting from the pandemic. caresyntax's digital platforms use 
proprietary software and AI to analyse large volumes of real-world data in and around the OR. This delivers powerful 
insights that can be used by care teams and a variety of critical stakeholders that can then use the data to assess and 
improve care, and raise overall efficiency. The funding will allow caresyntax to accelerate its expansion in key 
markets, further develop its cutting-edge AI capabilities, and build out its platforms. 
"caresyntax is helping bend the curve towards better patient outcomes and more efficient workflow through extracting 
unique insights from structured and unstructured data in surgery," said Dr. Anant Ahuja, Partner at PFM Health 
Sciences. "We are highly confident their technology platform will reduce clinical and business risks for all 
stakeholders in surgery, as it grows into a first-of-its-kind enterprise solution for data analytics in the operating 
room." 
caresyntax's growth comes at a critical time for hospitals. It is estimated that it could take up to a year to work 
through the surgical backlog, even operating at 10-20 percent above historical volume. Amidst the first wave of the 
COVID-19 pandemic, caresyntax offered hospitals the free-of-charge usage of its software to better manage scarce 
resources. 
Today's funding announcement rounds off a year of successful new partnerships. Relyens Group, the largest European 
medical malpractice reinsurer, relies on caresyntax to help manage surgical risk, utilising its platform for real-world 
data-based assessments linked to patient outcomes. The University Hospital of Strasbourg has used caresyntax's software 
applications to enable surgical training, which has led to better scores, an optimized learning curve, and improved 
risk management. Sheba Medical Center, the largest medical centre in the Middle East, signed a research partnership 
with caresyntax to predict surgical outcomes using AI and machine learning. 
About caresyntax: 
caresyntax is working to make mission-critical health care settings such as surgery, interventional radiology and 
obstetrics smarter and safer. The company's proprietary solutions leverage IoT, analytics and AI technologies to 
automate clinical and operational decision support for surgical teams and support all outcome contributors in the 
delivery and management of risk-bearing contracts. By integrating data from medical devices, electronic health records, 
and other sources inside the OR into a unified data platform, caresyntax helps caregivers better identify and manage 
risk, increase workflow efficiency, reduce surgical variability and improve operational or clinical outcomes at the 
point of care. Today, caresyntax technologies are used in more than 8,000 operating rooms worldwide, and support 
surgical teams in over 13 million surgeries per year. More information at www.caresyntax.com. 
Contact: 
Kekst CNC 
Philip Schaar 
E: surgicalai@kekstcnc.com 
End of Media Release 
=---------------------------------------------------------------------------------------------------------------------- 
Issuer: Caresyntax 
Key word(s): Health 
2021-04-28 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 

1189923 2021-04-28

Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1189923&application_name=news 
 

(END) Dow Jones Newswires

April 28, 2021 05:57 ET (09:57 GMT)

© 2021 Dow Jones News
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.